NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Cited by (377)

Items 201–300 of 377

1. Effects of antioxidants on cancer progression
   Sarah Schmidt, Xi Qiao, Martin O. Bergö · 2025 · EMBO Molecular Medicine
2. Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
   Katharina Lankes, Zonera Hassan, Josefina Doffo, Christian Schneeweis, Svenja Lier, Rupert Öllinger, Roland Rad, Oliver Holger Krämer, Ulrich Bernd Keller, Dieter Saur et al. · 2020 · Molecular Oncology
3. Drivers of Gene Expression Dysregulation in Pancreatic Cancer
   Swati Venkat, Abdulrahman A. Alahmari, Michael E. Feigin · 2021 · Trends in cancer
4. The NRF2-p97-NRF2 negative feedback loop
   Aryatara Shakya, Pengfei Liu, Jack Godek, Nicholas W. McKee, Matthew B. Dodson, Annadurai Anandhan, Aikseng Ooi, Joe G. N. Garcia, Max Costa, Eli Chapman et al. · 2023 · Redox Biology
5. Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
   Dan Wang, Ya‐Wei Bi, Liang‐Hao Hu, Yongde Luo, Jun‐Tao Ji, Albert H. Mao, Craig D. Logsdon, Ellen Li, James L. Abbruzzese, Zhao‐Shen Li et al. · 2019 · Cell Communication and Signaling
6. The Effects of Dietary Supplements that Overactivate the Nrf2/ARE System
   Robert E. Smith · 2019 · Current Medicinal Chemistry
7. HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis
   Alpha Raj Mekapogu, Zhihong Xu, Srinivasa P. Pothula, Chamini Jayamali Perera, Tony Pang, S. M. Zahid Hosen, Vishnu C. Damalanka, James W. Janetka, David Goldstein, Romano C. Pirola et al. · 2023 · Cancer Letters
8. Dysregulated ribosome quality control in human diseases
   Tom McGirr, Okan Onar, Seyed Mehdi Jafarnejad · 2024 · FEBS Journal
9. Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer
   Christopher J. Halbrook, Marina Pasca di Magliano, Costas Andreas Lyssiotis · 2018 · American Journal of Physiology-Gastrointestinal and Liver Physiology
10. Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition
    Takefumi Onodera, Isao Momose, Hayamitsu Adachi, Yohko Momose Yamazaki, Ryûichi Sawa, Shun‐ichi Ohba, Manabu Kawada · 2020 · Journal of Biological Chemistry
11. NRF2 signaling in cytoprotection and metabolism
    Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi · 2023
12. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival
    Peeter Karihtala, Katja Porvari, Ylermi Soini, Matti J. Eskelinen, Petri Juvonen, Kirsi‐Maria Haapasaari · 2018 · Oncology
13. A vinyl-decorated covalent organic framework for ferroptotic cancer therapy via visible-light-triggered cysteine depletion
    Qun Guan, Lele Zhou, Wei Duo Zhou, Yu‐Bin Dong · 2022 · Journal of Materials Chemistry B
14. Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma
    Anna Evans Phillips, Nilesh Shah, Amir Ali Borhani, Dhiraj Kumar Yadav, Randall E. Brand · 2018 · Pancreas
15. NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
    Sean Michael O'Cathail, Chieh‐Hsi Wu, Rachael J. Thomas, M. Hawkins, Tim Maughan, Annabelle Lewis · 2021 · Antioxidants
16. The Intricate Metabolism of Pancreatic Cancers
    Felipe Camelo, Anne Le · 2018 · Advances in experimental medicine and biology
17. Chemopreventive Effects of Dietary Isothiocyanates in Animal Models of Gastric Cancer and Synergistic Anticancer Effects With Cisplatin in Human Gastric Cancer Cells
    Hanne-Line Rabben, Yosuke Kodama, Masahiko Nakamura, Atle Magnar Bones, Timothy Cragin Wang, Duan Chen, Chun‐Mei Zhao, Anders Øverby · 2021 · Frontiers in Pharmacology
18. Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis
    Muyun Liu, Dan Wang, Yongde Luo, Liang‐Hao Hu, Ya‐Wei Bi, Jun‐Tao Ji, Haojie Huang, Guoqiang Wang, Liang Zhu, Jianjia Ma et al. · 2021 · Cell Death and Disease
19. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
    Ronnie Ren Jie Low, Wei‐Wen Lim, Paul M. Nguyen, Belinda Lee, Michael Christie, Antony Wilks Burgess, Peter Gibbs, Sean Michael Grimmond, Frédéric Hollande, Tracy L. Putoczki · 2021 · Cancers
20. Perspectives of TrxR1-based cancer therapies
    Elias S.J. Arnér · 2019 · Elsevier eBooks
21. Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
    Hong Dai, Razack Abdullah, Xiaoqiu Wu, Fangfei Li, Yuan Ma, Aiping Lü, Ge Zhang · 2022 · Frontiers in Cell and Developmental Biology
22. Role of ionizing radiation activated NRF2 in lung cancer radioresistance
    Qianqian Xu, Peiyu Zhang, Xiaoyan Han, Huwei Ren, Weiyue Yu, Wei Hao, Bowen Luo, Muhammad Imran Khan, Ni Chen · 2023 · International Journal of Biological Macromolecules
23. Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment
    Hans Peter Weitzenböck, Anna Gschwendtner, Christoph Wiesner, Maren Depke, Frank Schmidt, Franz Trautinger, Markus Hengstschläger, Harald Hundsberger, Mario Mikula · 2021 · Cancer Medicine
24. Challenges and Opportunities in Modeling Pancreatic Cancer
    Michael E. Feigin, David Arthur Tuveson · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
25. The Complex Roles of Redox and Antioxidant Biology in Cancer
    Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, Hozumi Motohashi · 2024 · Cold Spring Harbor Perspectives in Medicine
26. Translational alterations in pancreatic cancer: a central role for the integrated stress response
    Sauyeun Shin, Jacobo Solórzano, Mehdi Liauzun, Stéphane Pyronnet, Corinne Bousquet, Yvan Martineau · 2022 · NAR Cancer
27. The metabolic crosstalk between PIN1 and the tumour microenvironment
    Isabella Caligiuri, Vincenzo Canzonieri, Tomochiro Asano, Vinit Kumar, Flavio Rizzolio · 2023 · Seminars in Cancer Biology
28. Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications
    İlhan Yaylım, Melek Aru, Ammad Ahmad Farooqı, Mehmet Tolgahan Hakan, Brigitta Buttari, Marzia Arese, Luciano Saso · 2024 · Cancer Drug Resistance
29. N-Acetylcysteine Reduces the Pro-Oxidant and Inflammatory Responses during Pancreatitis and Pancreas Tumorigenesis
    Marie-Albane Minati, Maxime Libert, Hajar Dahou, Patrick Jacquemin, Mohamad Assi · 2021 · Antioxidants
30. Ozone at low concentrations does not affect motility and proliferation of cancer cells in vitro
    Manuela Costanzo, Alessandro Romeo, Barbara Cisterna, Laura Calderan, Paolo Bernardi, Viviana Covi, Gabriele Tabaracci, Manuela Malatesta · 2020 · European Journal of Histochemistry
31. SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu
    Kehua Pan, Xince Huang, Xiufen Jia · 2021 · Oncology Letters
32. Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells
    Hajar Dahou, Marie-Albane Minati, Patrick Jacquemin, Mohamad Assi · 2021 · Antioxidants
33. The Intricate Metabolism of Pancreatic Cancers
    Felipe S. Camelo, Anne Le · 2021 · Advances in experimental medicine and biology
34. Self-amplifying NRF2–EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer
    Laura Antonucci, Na Li, Ángeles Durán, Isidoro Cobo, Chiara Nicoletti, Kosuke Watari, Shuvro Prokash Nandi, Feng Zhu, Yongmei Zhao, Irene Riahi et al. · 2025 · Nature Cancer
35. Stem/progenitor cells in normal physiology and disease of the pancreas
    Mario Enrique Alvarèz Fallas, Sergio Pedraza‐Arévalo, Ana-Maria Cujba, Teodora Manea, Christopher Lambert, Rosario Morrugares, Rocı́o Sancho · 2021 · Molecular and Cellular Endocrinology
36. Extracellular arginine availability modulates eIF2α O-GlcNAcylation and heme oxygenase 1 translation for cellular homeostasis
    Yu-Wen Hung, C. Ouyang, X. Ping, Ye Qi, Yi-Chang Wang, H. Kung, D. Ann · 2023 · Journal of Biomedical Sciences
37. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
    Ming Gu, Yang Liu, Peng Xin, Wei Guo, Zimo Zhao, Yang Xu, Ruiyang Ma, Taiwei Jiao, Wenhui Zheng · 2024 · Cancer Letters
38. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
    Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Sotirios P. Fortis, Vassilis L. Tzounakas, Alkmini T. Anastasiadi, Panagiotis Sarantis, Sofia Vasileiadi, Ariadne Tsagarakis et al. · 2024 · International Journal of Molecular Sciences
39. Aldo-keto Reductase 1B10 (AKR1B10) Suppresses Sensitivity of Ferroptosis in TNBC by Activating the AKT/GSK3β/Nrf2/GPX4 Axis
    Shanli Wu, Gun Yang, Xiaosha Wen, Yi Lin, Shenglong Wang, Jing Wang, Quan Liu, Dixian Luo · 2025 · Frontiers in Bioscience-Landmark
40. An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
    Miranda Lin, Mei Gao, Prakash Krishnan Pandalai, Michael J. Cavnar, Joseph Kim · 2020 · Cancers
41. Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities
    Guowei Gong, Zhenxia Zhang, Yuzhong Zheng · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
42. NRF2 signaling plays an essential role in cancer progression through the NRF2-GPX2-NOTCH3 axis in head and neck squamous cell carcinoma
    Xiaoye Jin, Xiayuan Lou, Haoxiang Qi, Chao Zheng, Bo Li, Xuerong Siwu, Ren Liu, Qiao‐Li Lv, An Zhao, Jian Ruan et al. · 2024 · Oncogenesis
43. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma
    Juan Zhou, Xinxin Zhang, Huifang Tang, Jia Yu, Xuyu Zu, Zhizhong Xie, Xiaoyan Yang, Juan Hu, Fang Tan, Qing Li et al. · 2020 · Clinica Chimica Acta
44. Probing the characteristics and biofunctional effects of disease-affected cells and drug response via machine learning applications
    Deborah Mudali, Jaison Jeevanandam, Michael K. Danquah · 2020 · Critical Reviews in Biotechnology
45. Multifaceted control of mRNA translation machinery in cancer
    Lilas Alboushi, Angela P. Hackett, Parisa Naeli, Mostafa Bakhti, Seyed Mehdi Jafarnejad · 2021 · Cellular Signalling
46. Role of RONS and eIFs in Cancer Progression
    Yasmeen Ahmed Saleheldin Hassan Helmy, Salma Sayed Mohamed Mahmoud, Ebenezeri Erasto Ngowi, Vivian Gbordzor, Tao Li, Dongdong Wu, Xin‐Ying Ji · 2021 · Oxidative Medicine and Cellular Longevity
47. Reactive oxygen species and cancer
    Hyewon Kong, Navdeep S. Chandel · 2019 · Elsevier eBooks
48. Berberine triggers apoptosis through the PI3K/Akt pathways and Nrf2 by inducing ROS in papillary thyroid cancer
    Jing Li, Ziyi Zhu, Jing Ni, Lizi Ye, Xiaoyan Huang, Jing Dong, Yanhong Lu, Ling Yue · 2025 · Archives of Biochemistry and Biophysics
49. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras–PDAC model
    Qiang Zhang, Dongping Wei, Mingjia Tan, Haomin Li, Meredith Ann Morgan, Yi Sun · 2020 · Neoplasia
50. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma
    Keisuke Okuno, Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Tetsuji Takayama, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, Ajay Goel · 2023 · Biomedicines
51. Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
    Nicole Lintern, Andrew Malvern Smith, David George Jayne, Yazan S. Khaled · 2023 · Cancers
52. Suppression of the KRAS-NRF2 axis shifts arginine into the phosphocreatine energy system in pancreatic cancer cells
    Eros Di Giorgio, Himanshi Choudhary, Annalisa Ferino, Ylenia Cortolezzis, Emiliano Dalla, Francesca D’Este, Marina Comelli, Valentina Rapozzi, Luigi Emilio Xodo · 2023 · iScience
53. Decoupling of Nrf2 Expression Promotes Mesenchymal State Maintenance in Non-Small Cell Lung Cancer
    John D. Haley, Christian F. Ruiz, Emily D. Montal, Daifeng Wang, John D. Haley, Geoffrey D. Girnun · 2019 · Cancers
54. NRF2 and Primary Cilia: An Emerging Partnership
    Ana Martín-Hurtado, Isabel Lastres‐Becker, Antonio Cuadrado, Francesc R. García-Gonzalo · 2020 · Antioxidants
55. Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway
    Bingbing Dai, Jithesh Jose Augustine, Ya’an Kang, David Roife, Xinqun Li, Jenying Deng, Lin Tan, Leona A. Rusling, John N. Weinstein, Philip L. Lorenzi et al. · 2021 · Cell Death and Disease
56. Nrf2 expression in pancreatic stellate cells promotes progression of cancer
    Yu Tanaka, Shin Hamada, Ryotaro Matsumoto, Keiko Taguchi, Masayuki P. Yamamoto, Atsushi Masamune · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
57. Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
    Ziwei Yang, Tixin Han, Ruibin Yang, Yinuo Zhang, Yifei Qin, Jialu Hou, Fei Huo, Zhuan Feng, Yaxin Ding, Jiali Yang et al. · 2025 · Frontiers in Immunology
58. Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation
    Bryan James Mathis, Hideyuki Kato, Yuji Hiramatsu · 2022 · Cells
59. Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment
    Hoang Kieu Chi Ngo, Hoang Le, Young‐Joon Surh · 2023 · Journal of Cancer Prevention
60. NRF2: Translating the Redox Code
    Krishna Seshu Tummala, Filippos Kottakis, Nabeel M. Bardeesy · 2016 · Trends in Molecular Medicine
61. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma
    Lindsey A. Baker, David Arthur Tuveson · 2018 · Methods in molecular biology
62. EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
    Savita Bisht, Jens Nolting, Joerg Wenzel, Peter Brossart, Georg Feldmann · 2019 · Journal of Oncology
63. Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma
    Laner Shi, Xin Chun Shang, Kechao Nie, Qiang Xu, Na‐βei Chen, Zhangzhi Zhu · 2020 · Oncology Letters
64. Retinoic acid downregulates thiol antioxidant defences and homologous recombination while promotes A549 cells sensitization to cisplatin
    Vítor de Miranda Ramos, Juciano Gasparotto, Fabrício Figueiró, Amanda de Fraga Dias, Diana Carolina Rostirolla, Nauana Somensi, Helen Taís da Rosa, Lucas Kich Grün, Florencia María Barbé‐Tuana, Daniel Pens Gelain et al. · 2019 · Cellular Signalling
65. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel
    Negin Riazi Tabrizi, Mohammad Khalaj‐Kondori, Sahar Safaei, Mohammad Ali Amini, Hamidreza Hassanian, Mohadeseh Maghsoudi, Shima Hasani, Behzad Baradaran · 2023 · Molecular Biotechnology
66. Spatially defined microenvironment for engineering organoids
    Yilan Zhang, Fukang Qi, Peng Chen, Bi‐Feng Liu, Yiwei Li · 2024 · Biophysics Reviews
67. Ribosome biogenesis, altered metabolism and ribotoxic stress response in pancreatic ductal adenocarcinoma tumor microenvironment
    Sanjib Chaudhary, Jawed Akhtar Siddiqui, Ramesh Pothuraju, Rakesh Bhatia · 2025 · Cancer Letters
68. Discovery and Evaluation of C6-Substituted Pyrazolopyrimidine-Based Bisphosphonate Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase and Evaluation of Their Antitumor Efficacy in Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and Colorectal Cancer
    Rebecca Boutin, Hiu‐Fung Lee, Tian Lai Guan, Tan Trieu Nguyen, Xian Fang Huang, Daniel Dirck Waller, Jordan Lu, Iok In Christine Chio, René P. Michel, Michaël Sébag et al. · 2023 · Journal of Medicinal Chemistry
69. Quantitative proteomic analyses uncover regulatory roles of Nrf2 in human endothelial cells
    Karan Naresh Amin, Palanichamy Rajaguru, Takayoshi Suzuki, Koustav Sarkar, Kumar Ganesan, Kunka Mohanram Ramkumar · 2023 · Cell Stress and Chaperones
70. Diet-Induced Phospholipid Remodeling Dictates Ferroptosis Sensitivity and Tumorigenesis in the Pancreas
    Christian Felipe Ruiz, Xiangyu Ge, Rylee McDonnell, Sherry S. Agabiti, Daniel C. McQuaid, Andy Tang, Meera Kharwa, Jennifer Goodell, Rocío del M. Saavedra-Peña, Allison Wing et al. · 2026 · Cancer Discovery
71. Study on the Mechanism of FOXA2 Activation on Glutathione Metabolic Reprogramming Mediated by ETV4 Transcription to Facilitate Colorectal Cancer Malignant Progression
    Xiangcheng Zhang, Yali He, Jiayue Shen, Bingchuan Zhou, Huabo Qin, Shuai Zhang, Zixiang Huang · 2024 · Biochemical Genetics
72. A forward genetic screen identifies modifiers of rocaglate responsiveness
    Leo L. Shen, Lauren Pugsley, Regina Cencic, HanChen Wang, Francis Robert, Sai Kiran Naineni, Ananya Sahni, Geneviève Morin, Wenhan Zhang, Anastasia Nijnik et al. · 2021 · Scientific Reports
73. Kras in Organoids
    Derek K. Cheng, David Arthur Tuveson · 2018 · Cold Spring Harbor Perspectives in Medicine
74. Treating pancreatic cancer: more antioxidants more problems?
    Matthew S. Alexander, Joseph J. Cullen · 2018 · Expert Review of Gastroenterology & Hepatology
75. Refining antibiotic cocktail regimens for pseudo-germ-free mice and their impact on gut microbiome and pancreatic tumor proteomics
    Suraphan Panyod, Wei‐Kai Wu, Yen-Peng Lee, Tzung‐Yi Lin, Po-Cheng Kuo, Chen-Syuan Yen, Yi‐Hsun Chen, Hsiao-Li Chuang, I‐Hsuan Lo, Yu-Tang Yang et al. · 2025 · Journal of Advanced Research
76. NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions
    Megan D. Radyk, Barbara Scott Nelson, Mariana T. Ruckert, Christopher J. Halbrook, Mengrou Shan, Jonathan M. Alektiar, Brooke L. Lavoie, Lucie Salvatore, Wei Yan, Matthew D. Perricone et al. · 2026 · Nature Metabolism
77. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
78. LRRC45 accelerates bladder cancer development and ferroptosis inhibition via stabilizing NRF2 by competitively KEAP1 interaction
    Linwei Fan, Dingfan Guo, Chao Zhu, Chenqi Gao, Yu Wang, Fang Yin, Mengwei Liu, Yanyu Zhou, Tiancheng Wei, Xinxin Xiong et al. · 2024 · Free Radical Biology and Medicine
79. The potential impact of melanosomal pH and metabolism on melanoma
    Jaewon You, Maftuna Yusupova, Jonathan Hale Zippin · 2022 · Frontiers in Oncology
80. A new approach to assess drug sensitivity in cells for novel drug discovery
    Luca Mazzarella, Giuseppe Curigliano · 2018 · Expert Opinion on Drug Discovery
81. Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO
    Alison B. Ross, Darvesh Gorhe, Jenny Kim Kim, Stefanie J. Hodapp, Lela DeVine, Karina M. Chan, Iok In Christine Chio, Marko Jovanović, Marina Ayres Pereira · 2024 · Cell Reports Methods
82. Transcriptional Isoforms of NAD+ kinase regulate oxidative stress resistance and melanoma metastasis
    Graciela Cascio, Kelsey N. Aguirre, Kellsey P. Church, Riley O. Hughes, Leona A. Nease, Ines Delclaux, Hannah J. Davis, Elena Piskounova · 2024 · Redox Biology
83. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes
    Wenshuang Jia, Xiaoxia Gong, Zhen Ye, Na Li, Xianquan Zhan · 2023 · The EPMA Journal
84. Chemical proteomics to study metabolism, a reductionist approach applied at the systems level
    Md Yousuf Ali, Liron Bar‐Peled · 2024 · Cell chemical biology
85. The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice
    Ana S. Leal, Karen T. Liby · 2024 · International Journal of Molecular Sciences
86. The role of PKA/PP2B-mediated Drp1 phosphorylation and the subsequent EGFR inhibition in Cr(VI)-induced premature senescence
    Siwen Li, Yu Ma, Yuehui Liang, Ningjuan Liang, Shuzi Ye, Fang Xiao · 2021 · Ecotoxicology and Environmental Safety
87. RAS: Circuitry and therapeutic targeting
    Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
88. Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells
    Yongde Luo, Dan Wang, James L. Abbruzzese, Weiqin Lu · 2018 · Methods in molecular biology
89. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma
    Shuming Hu, Yuan Yuan, Ruolan Yan, Huikang Xie, Rong Cai, Jiaqian Xu · 2024 · Biochemical and Biophysical Research Communications
90. Dual regulation of Akt and glutathione caused by isoalantolactone effectively triggers human ovarian cancer cell apoptosis
    Zhoufan Xie, Jie Xu, Di Xiao, Jiachuan Lei, Jianqing J. Yu · 2023 · Acta Biochimica et Biophysica Sinica
91. Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer
    Chen Liang, Zeyin Rong, Abudureyimu Tuerhong, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Si Shi et al. · 2023 · International Journal of Molecular Sciences
92. Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers
    Jinghong Huang, Lei Zhang, Rui Xiang Yang, Lixia Yao, Jinming Gou, Dongdong Cao, Zeming Pan, Dongmei Li, Yuanming Pan, Wei Zhang · 2023 · Frontiers in Molecular Biosciences
93. Polyphenols as Potential Antioxidants for the Treatment of Intervertebral Disc Degeneration
    Xiaolong Li, Xiaoyu Yu, Yuao Tao, Yuzhu Xu, Xi Li, Jia-Dong Wang, Lele Zhang, Yuntao Wang, Fan Pan · 2024 · Current Medicinal Chemistry
94. Macrophage-induced reactive oxygen species in the initiation of pancreatic cancer: a mini-review
    Heike R. Döppler, Peter Störz · 2024 · Frontiers in Immunology
95. High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC
    Georgios Tsakonas, Alfonso Martín-Bernabé, Konstantinos Rounis, Pablo Moreno-Ruiz, Johan Botling, Luigi De Petris, Antti Ylipää, Artur Mezheyeuski, Patrick Micke, Arne Östman et al. · 2021 · Cancers
96. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma
    Lingyan Xiao, Qian Li, Yongbiao Huang, Zhijie Fan, Li Ma, Bo Liu, Xianglin Yuan · 2022 · Journal of Healthcare Engineering
97. Correlations of phosphorylated Nrf2 with responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiaxuan Yu, Tianze Yao, Min Zhang, Bingxin Li, Jiping Xie, Yi Wan, Zhantian Zhang, Shiyu Yang, Yuchuan Ge, Guangxi Sun et al. · 2025 · BMC Women s Health
98. Nrf2 Drives Epigenetic Reprogramming and Acts as the Master Regulator of KLF4 Expression and Activity in Arsenic‐Induced Transformation
    Ziwei Wang, Zhuoyue Bi, Jessica Bamrah, Yiran Qiu, Wenxuan Zhang, Bandar Saeed Almutairy, Haoyan Ji, John D. Haley, Chitra Thakur, Fei Chen · 2025 · Advanced Science
99. Identification of novel hub genes and lncRNAs related to the prognosis and progression of pancreatic cancer by microarray and integrated bioinformatics analysis
    Xing Liang, Junfeng Peng, Danlei Chen, Liang V. Tang, An-An Liu, Zhiping Fu, Ligang Shi, Keqi Wang, Chenghao Shao · 2021 · Gland Surgery
100. Metabolism in Pancreatic Cancer
     Ioannis Poursaitidis, Richard F. Lamb · 2018 · Springer eBooks